Science Explorer Back to mapMap
Discussion

Southern Biotechnology Associates

Research works
5
▼ 5% vs 2018-21
Citations
393
83.3 per fractional work
Top-10% rate
10.5%
all institutions 10.0%
Open access
52%
world 40%
International
15%
world 18%

Not ranked overall: Southern Biotechnology Associates is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Southern Biotechnology Associates work in?

In all years, 70% of research at Southern Biotechnology Associates is in Health Sciences, 26% in Life Sciences. Its largest fields are Medicine (68%), Immunology and Microbiology (11%), Biochemistry, Genetics and Molecular Biology (9%). It does 1.5× the world's share of Health Sciences.

Life Sciences26%Physical Sciences2%Health Sciences70%Social Sciences2%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 8 fields, with their numbers
    1. Medicine368.1%
    2. Health Professions02.1%
    1. Immunology and Microbiology010.6%
    2. Biochemistry, Genetics and Molecular Biology08.5%
    3. Agricultural and Biological Sciences04.3%
    4. Neuroscience02.1%
    1. Environmental Science02.1%
    1. Social Sciences02.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

What are the most cited papers from Southern Biotechnology Associates?

The most cited paper from Southern Biotechnology Associates is "An Exposed Domain in the Severe Acute Respiratory Syndrome Coronavirus Spike Protein Induces Neutralizing Antibodies" (Tong Zhou, Hong Wang, Danlin Luo et al., 2004), with 82 citations. Next come "Time to Onset of Response of AbobotulinumtoxinA in the Treatment of Glabellar Lines: A Subset Analysis of Phase 3 Clinical Trials of a New Botulinum Toxin Type A" (29) and "The enigmatic role of glutamyl aminopeptidase (BP‐1/6C3 antigen) in immune system development" (24).

Most cited papers
#PaperReleasedCitations
1 An Exposed Domain in the Severe Acute Respiratory Syndrome Coronavirus Spike Protein Induces Neutralizing Antibodies Tong Zhou, Hong Wang, Danlin Luo et al. · Journal of Virology Open access 11 Jun 2004 82
2 Time to Onset of Response of AbobotulinumtoxinA in the Treatment of Glabellar Lines: A Subset Analysis of Phase 3 Clinical Trials of a New Botulinum Toxin Type A Joel Schlessinger, Gary D. Monheit, Michael A. C. Kane et al. · Dermatologic Surgery 11 Jul 2011 29
3 The enigmatic role of glutamyl aminopeptidase (BP‐1/6C3 antigen) in immune system development Ji‐Yang Wang, Qun Lin, Qi Wu et al. · Immunological Reviews Review Feb 1998 24
4 SCAI publications committee manual of standard operating procedures Molly Szerlip et al. · Catheterization and Cardiovascular Interventions Open access 14 Feb 2020 15
5 Dysmyelinating leukodystrophies: “LACK Proper Myelin” H. P. Hatten · Pediatric Radiology Nov 1991 14
All 9 most cited papers, with filters and sorting

Which research topics does Southern Biotechnology Associates publish most on?

By volume in 2022-now: Health disparities and outcomes, Health Policy Implementation Science, Community Health and Development and COVID-19 Clinical Research Studies.

  1. 1 Health disparities and outcomes Health 0 works
  2. 2 Health Policy Implementation Science General Health Professions 0 works
  3. 3 Community Health and Development General Health Professions 0 works
  4. 4 COVID-19 Clinical Research Studies Infectious Diseases 0 works
  5. 5 Respiratory viral infections research Epidemiology 0 works
  6. 6 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available51.8%not open48.2%

World: 40% of research is openly available.

with international co-authors14.6%domestic only85.4%

World: 18% is written across borders.

How has Southern Biotechnology Associates's research output changed?

Output in 2022-2025 was 5% lower than in 2018-2021.

1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Southern Biotechnology Associates as a percentage of every work published that year, 0.0000031% in 2023.

0.00020%0.00040%Southern Biotechnology Associates0.00000036% in 20241990200020102020

Fractional works of Southern Biotechnology Associates over all fractional works that year. How the balance of science has shifted.

Other research institutions in Birmingham

All research institutions in Birmingham

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Southern Biotechnology Associates. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.